Opiranserin for Minimally Invasive Cholecystectomy
Recruiting
N/A
Interventional Study
Cholecystectomy, Laparoscopic
Cholecystectomy, Robotic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 19 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 88 (estimated)
- Sponsor
- Gangnam Severance Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate whether the combination therapy of opiranserin and acetaminophen is non-inferior to the combination of non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen for postoperative pain management after minimally invasive cholecystectomy.
This is a single-center, randomized, controlled, non-inferiority clinical trial in adult patients undergoing minim…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patient undergoing minimally invasive cholecystectomy
Exclusion Criteria:
* Known hypersensitivity or allergy to acetaminophen, NSAIDs, opiranserin, or fentanyl.
* pre-existing chronic pain,
* clinically significant ECG findings (QRS \> 200 msec, QTcF \>450 msec)
* sev…
Contacts